QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

20,995 signal articles · 508 in last 24h · 103,318 total before filter · latest 23m ago
508last 24h
2497last 7d
483● bullish (7d)
253● bearish (7d)
197publishers
AllMacro246Earnings1472M&A138Regulatory16Product4Analyst29
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Paramount Skydance (PSKY) Gets EU Clearance For Warner Bros. Discovery Acquisition
Simply Wall St.13h agoneutral
Paramount Skydance (PSKY) Gets EU Clearance For Warner Bros. Discovery Acquisition

Paramount Skydance (NasdaqGS:PSKY) has received formal clearance from the European Commission for its acquisition of Warner Bros. Discovery. This approval addresses a key regulatory step in Europe after reviews in multiple major jurisdictions. The decision was announced as most global regulatory approvals for the transaction have now been secured. For investors following Paramount Skydance, the company operates at the intersection of filmed entertainment, television and streaming, where...

Caption: Chipotle is removing jalapeños from its menu in Minnesota after potentially being linked to the Salmonella outbreak, according to reports. 🌶️

The stock dipped nearly 9% following the news on Tuesday.

Explore more premium news and analysis on Chipotle in AlphaSpace:
Yahoo Finance Video16h agoneutralVIDEO
Caption: Chipotle is removing jalapeños from its menu in Minnesota after potentially being linked to the Salmonella outbreak, according to reports. 🌶️ The stock dipped nearly 9% following the news on Tuesday. Explore more premium news and analysis on Chipotle in AlphaSpace:

Caption: Chipotle is removing jalapeños from its menu in Minnesota after potentially being linked to the Salmonella outbreak, according to reports. 🌶️ The stock dipped nearly 9% following the news on Tuesday. Explore more premium news and analysis on Chipotle in AlphaSpace:

Chipotle stock plunges due to salmonella concerns: AlphaSpace check
Yahoo Finance Video18h agobearishVIDEO
Chipotle stock plunges due to salmonella concerns: AlphaSpace check

Yahoo Finance Senior Reporter Brooke DiPalma and Market Domination host Josh Lipton take a closer look at one of Tuesday's trending stories: Chipotle (CMG) pulling its jalapeños due to salmonella concerns. Watch the video above to learn more. Yahoo Finance's AlphaSpace is a premium investment platform that combines data, charting, news, analysis, and more to help retail investors understand markets.

Flag Ship Acquisition Targets AI Compute, Aircraft Engines for Cash Flow
MarketBeat21h agoneutral
Flag Ship Acquisition Targets AI Compute, Aircraft Engines for Cash Flow

Flag Ship Acquisition (NASDAQ:ETHZ) executives, speaking during a Forum Markets presentation hosted by Force Family Office, outlined a strategy centered on acquiring cash-generating real-world assets while maintaining the option to fractionalize and tokenize those assets as the market develops. Joh

Bloomberg21h agoneutral
Chipotle Pulled Jalapeños Tied to Minnesota Salmonella Cases

(Bloomberg) -- Chipotle Mexican Grill Inc. removed jalapeños from multiple stores in Minnesota after learning the peppers may be linked to a salmonella outbreak in the state that’s sickened 110 people.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallApple’s New CEO Taps Retired Hardware Executive for Management TeamQatar, Bessent Signal Progres

SRX Global Acquires Stake in Vistagen Therapeutics
InvestorsHub23h agoneutral
SRX Global Acquires Stake in Vistagen Therapeutics

SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).

Brokers split on AstraZeneca merger talk as shares recover some ground
Proactive1d agoneutral
Brokers split on AstraZeneca merger talk as shares recover some ground

Citi has told clients that a large chunk of deal risk is already in AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) share price after Monday's sharp fall, while Deutsche Bank sees clear parallels with the drugmaker's Alexion acquisition five years ago. The two notes are the second-day response to a...

AstraZeneca (LSE:AZN) Is In Merger Talks With Bristol Myers For $400 Billion
Simply Wall St.1d agoneutral
AstraZeneca (LSE:AZN) Is In Merger Talks With Bristol Myers For $400 Billion

AstraZeneca (LSE:AZN) is reported to be in advanced merger talks with Bristol Myers Squibb. The potential deal could create a combined pharmaceutical company valued at about US$400b. The transaction, if completed, would rank among the largest in the sector and could significantly affect competitive positions in oncology. Regulators are expected to review any agreement closely due to overlapping product portfolios. AstraZeneca is a global pharmaceutical company with a significant focus on...

Chinese robot maker Unitree seen worth over $7.4 billion yuan after IPO, Citic says
Reuters1d agoneutral
Chinese robot maker Unitree seen worth over $7.4 billion yuan after IPO, Citic says

Chinese robot maker Unitree Technology is expected to be valued ‌at more than 50 billion yuan ($7.4 billion) after its planned ‌Shanghai IPO, according to a report by Citic Securities, which is sponsoring the initial ​public offering. Citic Securities expected the Hangzhou-based company to be worth 50.6 billion to 55.9 billion yuan six to 12 months after listing later this month. The valuation report, distributed to investors and seen by ‌Reuters, is largely seen ⁠as guidance ahead of Wednesday's IPO price enquiry.

SpaceX Set for First Quarterly Results Since IPO as Investors Assess Valuation
InvestorsHub1d agoneutral
SpaceX Set for First Quarterly Results Since IPO as Investors Assess Valuation

SpaceX (NASDAQ:SPCX) is due to publish its quarterly results after the close of trading on Tuesday, marking the company’s first earnings report since its highly anticipated stock market debut. The release is expected to provide investors with a clearer picture of whether the company’s financial performance supports the ambitious growth expectations that accompanied its listing, particularly as it continues to invest heavily in artificial intelligence and space technologies.